Srinivasan Babu

This inventor holds 18 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Agouron Pharmaceuticals, Inc., Genentech, Inc., G.d. Searle & Company. Active years: 1996-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srinivasan Babu. Retrieved from https://idiyas.com/inventor/srinivasan-babu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 6.9

ph-index = 4

Forward Citations = 54(Granted Patents)

Location History:

San Diego, CA (US) (1996 - 2014)
South San Francisco, CA (US) (2013 - 2016)

Company Filing History:

8 out of 174

Agouron Pharmaceuticals, Inc.

G.d. Searle & Company

Sumitomo Chemical Company, Limited

patents

7. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2016

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9315471 - Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof (2016-04-19),

2. 8895729 - Process for making thienopyrimidine compounds (2014-11-25),

3. 8785651 - Method for manufacturing a boronic acid ester compound (2014-07-22),

4. 8461328 - Tricyclic heterocyclic compounds, compositions and methods of use thereof (2013-06-11),

5. 8431694 - Process for making thienopyrimidine compounds (2013-04-30),

6. 8354528 - Process for making thienopyrimidine compounds (2013-01-15),

7. 7173059 - Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same (2007-02-06),

8. 6774243 - Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates (2004-08-10),

9. 6465661 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors (2002-10-15),

10. 6392067 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors (2002-05-21),

11. 6355807 - Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates (2002-03-12),

12. 6316625 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors (2001-11-13),

13. 6117999 - Methods of making HIV-protease inhibitors and intermediates for making (2000-09-12),

14. 6084107 - Intermediates for making HIV-protease inhibitors (2000-07-04),

15. 5925759 - Methods of making HIV-protease inhibitors and intermediates for making (1999-07-20),

Title: Innovations of Srinivasan Babu

Introduction

Srinivasan Babu is a prominent inventor based in San Diego, California, known for his significant contributions to the field of pharmaceuticals. With a total of 18 patents to his name, he has made remarkable advancements in the development of compounds that have potential therapeutic applications, particularly in cancer treatment.

Latest Patents

Among his latest patents is a process for making hydroxylated cyclopentapyrimidine compounds and salts thereof. This invention provides new methods for making and purifying salts of these compounds, which serve as AKT inhibitors used in treating diseases such as cancer. Another notable patent involves the process for making thienopyrimidine compounds, specifically the dual mTOR/PI3K inhibitor GDC-0980. This compound has a complex structure and includes various stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts.

Career Highlights

Srinivasan Babu has worked with several esteemed companies in the pharmaceutical industry, including Agouron Pharmaceuticals, Inc. and Genentech, Inc. His work in these organizations has contributed to the development of innovative therapies that address critical health challenges.

Collaborations

Throughout his career, Srinivasan has collaborated with notable colleagues such as Travis Paul Remarchuk and Kim F Albizati. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Srinivasan Babu's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to impact the development of important therapeutic compounds.

Profile summary based on public USPTO records.